Veana Therapeutics Overview
- Year Founded
-
2012
- Status
-
Private
- Employees
-
2
- Latest Deal Type
-
2ndary - Private
- Investors
-
9
Veana Therapeutics General Information
Description
Operator of an early clinical-stage company intended to develop oral mitochondrial inhibitors for treating various cancers. The company offers a safe and effective oral therapeutic intended to kill cancer cells selectively and is based on orally bioavailable anti-cancer agents that kill cancer cells and stimulate the immune system to boost the immunological responses in cancer patients, enabling patients to have a better quality of life during and after the treatment of cancer.
Contact Information
Website
www.veana-therapeutics.comCorporate Office
- 4640 Southwest Macadam
- Suite 120
- Portland, OR 97239
- United States
Corporate Office
- 4640 Southwest Macadam
- Suite 120
- Portland, OR 97239
- United States
Veana Therapeutics Timeline
Veana Therapeutics Valuation & Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 11. Secondary Transaction - Private | Completed | Clinical Trials - Phase 1 | ||||
| 10. Seed Round | 19-Jun-2024 | Completed | Clinical Trials - Phase 1 | |||
| 9. Accelerator/Incubator | Completed | Clinical Trials - Phase 1 | ||||
| 8. Angel (individual) | 15-Jul-2023 | Completed | Clinical Trials - Phase 1 | |||
| 7. Seed Round | 24-Oct-2022 | Completed | Clinical Trials - Phase 1 | |||
| 6. Grant | 24-Jan-2022 | Completed | Pre-Clinical Trials | |||
| 5. Grant | 01-Aug-2021 | Completed | Pre-Clinical Trials | |||
| 4. Seed Round | 11-Nov-2020 | Completed | Pre-Clinical Trials | |||
| 3. Grant | 28-Nov-2018 | $350K | $9.7M | Completed | Pre-Clinical Trials | |
| 2. Angel (individual) | 21-May-2018 | $542K | $9.7M | Completed | Pre-Clinical Trials |
Veana Therapeutics Cap Table
| Stock | # of Shares Authorized |
Par Value | Dividend Rate (%) | Original Issue Price |
Liquidation | Liquidation Pref. Multiple |
Conversion Price | % Owned |
|---|---|---|---|---|---|---|---|---|
| Seed 2B | ||||||||
| Seed 2A | ||||||||
| Seed | 6,907,069 | $0.000100 | $0.18 | $0.18 | 1x | $0.18 | 9.44% |
VC Exit Predictor
See how our proprietary methodology utilizes historical data sets to synthesize the likelihood of an acquisition, IPO, or no exit event. Get a detailed look at the calculations behind our predictions.
Veana Therapeutics Signals
Veana Therapeutics Investors (9)
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds |
|---|---|---|---|---|
| CANCER FUND | Venture Capital | Minority | ||
| Alliance of Angels | Angel Group | Minority | ||
| Portfolia | Venture Capital | Minority | ||
| Business Oregon | Government | |||
| National Institutes of Health | Government |
Veana Therapeutics FAQs
-
When was Veana Therapeutics founded?
Veana Therapeutics was founded in 2012.
-
Where is Veana Therapeutics headquartered?
Veana Therapeutics is headquartered in Portland, OR.
-
What is the size of Veana Therapeutics?
Veana Therapeutics has 2 total employees.
-
What industry is Veana Therapeutics in?
Veana Therapeutics’s primary industry is Drug Discovery.
-
Is Veana Therapeutics a private or public company?
Veana Therapeutics is a Private company.
-
What is Veana Therapeutics’s current revenue?
The current revenue for Veana Therapeutics is .
-
How much funding has Veana Therapeutics raised over time?
Veana Therapeutics has raised $12.6M.
-
Who are Veana Therapeutics’s investors?
CANCER FUND, Alliance of Angels, Portfolia, Business Oregon, and National Institutes of Health are 5 of 9 investors who have invested in Veana Therapeutics.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process